A pilot study to compare the effect of oestrogen combined with a progestogen in the form of either an oral contraceptive (OC) or hormone replacement therapy (HRT) on bone mineral density (BMD) in normogonadotropic hypoestrogenic anovulatory women.

Trial Profile

A pilot study to compare the effect of oestrogen combined with a progestogen in the form of either an oral contraceptive (OC) or hormone replacement therapy (HRT) on bone mineral density (BMD) in normogonadotropic hypoestrogenic anovulatory women.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Estradiol/dydrogesterone (Primary) ; Ethinylestradiol/levonorgestrel (Primary) ; Estradiol
  • Indications Hypogonadism; Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 03 Sep 2012 Planned End Date changed to 30 Sep 2012.
    • 21 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top